- Home
- KEQU vs TVGN Comparison
KEQU vs TVGN Comparison
Compare KEQU & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEQU
- TVGN
- Stock Information
- Founded
- KEQU 1906
- TVGN 2020
- Country
- KEQU United States
- TVGN United States
- Employees
- KEQU N/A
- TVGN N/A
- Industry
- KEQU Medical Specialities
- TVGN Blank Checks
- Sector
- KEQU Industrials
- TVGN Finance
- Exchange
- KEQU Nasdaq
- TVGN Nasdaq
- Market Cap
- KEQU 183.3M
- TVGN 174.4M
- IPO Year
- KEQU N/A
- TVGN N/A
- Fundamental
- Price
- KEQU $60.60
- TVGN $1.21
- Analyst Decision
- KEQU
- TVGN
- Analyst Count
- KEQU 0
- TVGN 0
- Target Price
- KEQU N/A
- TVGN N/A
- AVG Volume (30 Days)
- KEQU 33.7K
- TVGN 1.7M
- Earning Date
- KEQU 03-05-2025
- TVGN 02-20-2025
- Dividend Yield
- KEQU N/A
- TVGN N/A
- EPS Growth
- KEQU 168.79
- TVGN N/A
- EPS
- KEQU 6.31
- TVGN N/A
- Revenue
- KEQU $199,637,000.00
- TVGN N/A
- Revenue This Year
- KEQU N/A
- TVGN N/A
- Revenue Next Year
- KEQU N/A
- TVGN N/A
- P/E Ratio
- KEQU $9.25
- TVGN N/A
- Revenue Growth
- KEQU N/A
- TVGN N/A
- 52 Week Low
- KEQU $27.00
- TVGN $0.26
- 52 Week High
- KEQU $67.20
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- KEQU 61.27
- TVGN 49.94
- Support Level
- KEQU $54.02
- TVGN $1.20
- Resistance Level
- KEQU $62.63
- TVGN $1.57
- Average True Range (ATR)
- KEQU 3.62
- TVGN 0.16
- MACD
- KEQU -1.00
- TVGN 0.02
- Stochastic Oscillator
- KEQU 49.92
- TVGN 38.04
About KEQU Kewaunee Scientific Corporation
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.